The DOI matches its OpenAlex record; 68 of the 68 references it cites were found in a registry or an index.
Toward transcriptional therapies for the failing heart: chemical screens to modulate genes
Open accessAbstract
In response to acute and chronic stresses, the heart frequently undergoes a remodeling process that is accompanied by myocyte hypertrophy, impaired contractility, and pump failure, often culminating in sudden death. The existence of redundant signaling pathways that trigger heart failure poses challenges for therapeutic intervention. Cardiac remodeling is associated with the activation of a pathological gene program that weakens cardiac performance. Thus, targeting the disease process at the level of gene expression represents a potentially powerful therapeutic approach. In this review, we describe strategies for normalizing gene expression in the failing heart with small molecules that control signal transduction pathways directed at transcription factors and associated chromatin-modifying enzymes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Self-citationCardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Self-citationHistone and chromatin cross-talk
Fischle, W., Wang, Y., & Allis, C. D. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00013-9 · Cited by 1,207
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C.-L., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,052
Self-citationClass II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy
Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00861-9 · Cited by 973
Self-citationSeven-transmembrane-spanning receptors and heart function
Rockman, H. A., Koch, W. J., & Lefkowitz, R. J. (2002) · Nature · doi:10.1038/415206a · Cited by 938
Prognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension
Devereux, R. B. (2004) · JAMA · doi:10.1001/jama.292.19.2350 · Cited by 881
Hypertrophy of the Heart: A New Therapeutic Target?
Frey, N., Katus, H. A., Olson, E. N., & Hill, J. A. (2004) · Circulation · doi:10.1161/01.cir.0000120390.68287.bb · Cited by 851
Self-citationPost-translational modifications regulate microtubule function
Westermann, S., & Weber, K. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1260 · Cited by 717
Prognostic implications of left ventricular hypertrophy
Vakili, B. A., Okin, P. M., & Devereux, R. B. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113218 · Cited by 712
Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy
Molkentin, J. D., & Dorn II, G. W. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.391 · Cited by 689
MEF2: a calcium-dependent regulator of cell division, differentiation and death
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)02031-x · Cited by 687
Self-citationClass II histone deacetylases: versatile regulators
Verdin, E., Dequiedt, F., & Kasler, H. G. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00073-8 · Cited by 664
Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymes
Gschwendt, M., Dieterich, S., Rennecke, J., Kittstein, W., Mueller, H.-J., & Johannes, F.-J. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00785-5 · Cited by 644
Chang, S., McKinsey, T. A., Zhang, C. L., Richardson, J. A., Hill, J. A., & Olson, E. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8467-8476.2004 · Cited by 613
Self-citationGrozinger, C. M., & Schreiber, S. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140199597 · Cited by 588
Myosin heavy chain isoform expression in the failing and nonfailing human heart
Miyata, S., Minobe, W., Bristow, M. R., & Leinwand, L. A. (2000) · Circulation Research · doi:10.1161/01.res.86.4.386 · Cited by 538
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260501497 · Cited by 517
Self-citationSmall Molecule Modulators of Histone Acetyltransferase p300
Balasubramanyam, K., Swaminathan, V., Ranganathan, A., & Kundu, T. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301580200 · Cited by 515
Sugden, P. H., & Clerk, A. (1998) · Circulation Research · doi:10.1161/01.res.83.4.345 · Cited by 513
Vega, R. B., Harrison, B. C., Meadows, E., Roberts, C. R., Papst, P. J., Olson, E. N., & McKinsey, T. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8374-8385.2004 · Cited by 511
Self-citationMyocardial Gene Expression in Dilated Cardiomyopathy Treated with Beta-Blocking Agents
Lowes, B. D., Gilbert, E. M., Abraham, W. T., Minobe, W. A., Larrabee, P., Ferguson, D., Wolfel, E. E., Lindenfeld, J., Tsvetkova, T., Robertson, A. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012630 · Cited by 501
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477
Self-citationStress Pathways and Heart Failure
Chien, K. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80043-4 · Cited by 446
Congestive Heart Failure: Fifty Years of Progress
Braunwald, E., & Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.102.suppl_4.iv-14 · Cited by 437
Czubryt, M. P., McAnally, J., Fishman, G. I., & Olson, E. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337639100 · Cited by 418
Self-citationMyosin heavy chain gene expression in human heart failure.
Nakao, K., Minobe, W., Roden, R., Bristow, M. R., & Leinwand, L. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119776 · Cited by 413
Lau, O. D., Kundu, T. K., Soccio, R. E., Ait-Si-Ali, S., Khalil, E. M., Vassilev, A., Wolffe, A. P., Nakatani, Y., Roeder, R. G., & Cole, P. A. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80452-9 · Cited by 394
Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
Haq, S., Choukroun, G., Kang, Z. B., Ranu, H., Matsui, T., Rosenzweig, A., Molkentin, J. D., Alessandrini, A., Woodgett, J., Hajjar, R., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.1.117 · Cited by 392
Sizing up the heart: development redux in disease
Olson, E. N., & Schneider, M. D. (2003) · Genes & Development · doi:10.1101/gad.1110103 · Cited by 385
Self-citationMutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease
Wang, L., Fan, C., Topol, S. E., Topol, E. J., & Wang, Q. (2003) · Science · doi:10.1126/science.1088477 · Cited by 379
Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly
Niimura, H., Patton, K. K., McKenna, W. J., Soults, J., Maron, B. J., Seidman, J. G., & Seidman, C. E. (2002) · Circulation · doi:10.1161/hc0402.102990 · Cited by 363
Yang, J., Rothermel, B., Vega, R. B., Frey, N., McKinsey, T. A., Olson, E. N., Bassel-Duby, R., & Williams, R. S. (2000) · Circulation Research · doi:10.1161/01.res.87.12.e61 · Cited by 354
Self-citationHypertrophic cardiomyopathy:a paradigm for myocardial energy depletion
Ashrafian, H., Redwood, C., Blair, E., & Watkins, H. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00081-7 · Cited by 349
Kook, H., Lepore, J. J., Gitler, A. D., Lu, M. M., Wing-Man Yung, W., Mackay, J., Zhou, R., Ferrari, V., Gruber, P., & Epstein, J. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19137 · Cited by 332
Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor
Naya, F. J., Black, B. L., Wu, H., Bassel-Duby, R., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Nature Medicine · doi:10.1038/nm789 · Cited by 327
Self-citationMyocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
Rothermel, B. A., McKinsey, T. A., Vega, R. B., Nicol, R. L., Mammen, P., Yang, J., Antos, C. L., Shelton, J. M., Bassel-Duby, R., Olson, E. N., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614798 · Cited by 294
Self-citationIdentification of a Signal-Responsive Nuclear Export Sequence in Class II Histone Deacetylases
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6312-6321.2001 · Cited by 284
Self-citationDose-dependent Blockade to Cardiomyocyte Hypertrophy by Histone Deacetylase Inhibitors
Antos, C. L., McKinsey, T. A., Dreitz, M., Hollingsworth, L. M., Zhang, C.-L., Schreiber, K., Rindt, H., Gorczynski, R. J., & Olson, E. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303113200 · Cited by 269
Self-citationMorisco, C., Zebrowski, D., Condorelli, G., Tsichlis, P., Vatner, S. F., & Sadoshima, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14466 · Cited by 258
Cardiac p300 Is Involved in Myocyte Growth with Decompensated Heart Failure
Yanazume, T., Hasegawa, K., Morimoto, T., Kawamura, T., Wada, H., Matsumori, A., Kawase, Y., Hirai, M., & Kita, T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.10.3593-3606.2003 · Cited by 238
Sano, M., Abdellatif, M., Oh, H., Xie, M., Bagella, L., Giordano, A., Michael, L. H., DeMayo, F. J., & Schneider, M. D. (2002) · Nature Medicine · doi:10.1038/nm778 · Cited by 236
Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis
Youn, H.-D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4323 · Cited by 223
Protein kinase D: an intracellular traffic regulator on the move
Van Lint, J., Rykx, A., Maeda, Y., Vantus, T., Sturany, S., Malhotra, V., Vandenheede, J. R., & Seufferlein, T. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02262-6 · Cited by 220
Chang, H.-M., Paulson, M., Holko, M., Rice, C. M., Williams, B. R. G., Marié, I., & Levy, D. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400567101 · Cited by 212
Herron, T. J., & McDonald, K. S. (2002) · Circulation Research · doi:10.1161/01.res.0000022879.57270.11 · Cited by 203
Histone Deacetylase 4 Possesses Intrinsic Nuclear Import and Export Signals
Wang, A. H., & Yang, X.-J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5992-6005.2001 · Cited by 183
A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials
Piekarz, R., & Bates, S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383980 · Cited by 174
Activation of cardiac Cdk9 represses PGC‐1 and confers a predisposition to heart failure
Sano, M., Wang, S. C., Shirai, M., Scaglia, F., Xie, M., Sakai, S., Tanaka, T., Kulkarni, P. A., Barger, P. M., Youker, K. A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600351 · Cited by 165
Calcium Regulates Transcriptional Repression of Myocyte Enhancer Factor 2 by Histone Deacetylase 4
Youn, H.-D., Grozinger, C. M., & Liu, J. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000304200 · Cited by 163
Haworth, R. S., Cuello, F., Herron, T. J., Franzen, G., Kentish, J. C., Gautel, M., & Avkiran, M. (2004) · Circulation Research · doi:10.1161/01.res.0000149299.34793.3c · Cited by 148
Nebigil, C. G., Jaffré, F., Messaddeq, N., Hickel, P., Monassier, L., Launay, J., & Maroteaux, L. (2003) · Circulation · doi:10.1161/01.cir.0000074224.57016.01 · Cited by 144
Ablation of Serotonin 5-HT2BReceptors in Mice Leads to Abnormal Cardiac Structure and Function
Nebigil, C. G., Hickel, P., Messaddeq, N., Vonesch, J., Douchet, M.-P., Monassier, L., György, K., Matz, R. L., Andriantsitohaina, R., Manivet, P., et al. (2001) · Circulation · doi:10.1161/01.cir.103.24.2973 · Cited by 144
Cardiac histone acetylation – therapeutic opportunities abound
McKinsey, T. A., & Olson, E. N. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.02.002 · Cited by 142
Self-citationControl of Cardiac Growth and Function by Calcineurin Signaling
Vega, R. B., Bassel‐Duby, R., & Olson, E. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300023200 · Cited by 132
Self-citationSequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2
Han, A., Pan, F., Stroud, J. C., Youn, H., Liu, J. O., & Chen, L. (2003) · Nature · doi:10.1038/nature01555 · Cited by 129
Regulation of MEF2 by p38 MAPK and Its Implication in Cardiomyocyte Biology
Han, J., & Molkentin, J. D. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00039-6 · Cited by 129
Inhibitors of Protein Kinase Signaling Pathways
Force, T. L., Kuida, K., Namchuk, M., Parang, K., & Kyriakis, J. M. (2004) · Circulation · doi:10.1161/01.cir.0000118538.21306.a9 · Cited by 128
Targeted Inhibition of Calcineurin in Pressure-overload Cardiac Hypertrophy
Hill, J. A., Rothermel, B. A., Yoo, K., Cabuay, B. M., Demetroulis, E., Weiss, R. M., Kutschke, W. J., Bassel‐Duby, R., & Williams, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110722200 · Cited by 119
van Rooij, E., Doevendans, P. A., Crijns, H. J. G. M., Heeneman, S., Lips, D. J., van Bilsen, M., Williams, R. S., Olson, E. N., Bassel‐Duby, R., Rothermel, B. A., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000118597.54416.00 · Cited by 116
Self-citationAbraham, W. T., Gilbert, E. M., Lowes, B. D., Minobe, W. A., Larrabee, P. S., Roden, R. L., Dutcher, D. L., Sederberg, J., Lindenfeld, J., Wolfel, E. E., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402039 · Cited by 113
Left Ventricular Hypertrophy: The Next Treatable, Silent Killer?
Gardin, J. M., & Lauer, M. S. (2004) · JAMA · doi:10.1001/jama.292.19.2396 · Cited by 111
Prognostic significance of left ventricular mass change during treatment of hypertension
Devereux, R. B., Wachtell, K., & Gerdts, E. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.02.043 · Cited by 96
Bush, E. W., Fielitz, J., Melvin, L., Arnold, M., McKinsey, T. A., Plichta, R. P., & Olson, E. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308723101 · Cited by 94
Self-citationThe CRM1 Nuclear Export Receptor Controls Pathological Cardiac Gene Expression
Harrison, B. C., Roberts, C. R., Hood, D. B., Sweeney, M., Gould, J. M., Bush, E. W., & McKinsey, T. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10636-10649.2004 · Cited by 80
Self-citationCalcineurin inhibition and cardiac hypertrophy: A matter of balance
Leinwand, L. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051033698 · Cited by 61
Davis, F. J., Pillai, J. B., Gupta, M., & Gupta, M. P. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00789.2004 · Cited by 44
Cited by
Haberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526
Self-citationMicroRNA-133 controls cardiac hypertrophy
Carè, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M.-L., Segnalini, P., Gu, Y., Dalton, N. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1582 · Cited by 1,776
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657
Self-citationIL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N. J., & Lee, R. T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30634 · Cited by 1,044
MEF2: a central regulator of diverse developmental programs
Potthoff, M. J., & Olson, E. N. (2007) · Development · doi:10.1242/dev.008367 · Cited by 834
Self-citation
Metadata
- Authors
- McKinsey, T. A., & Olson, E. N.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2005-03-01
- Volume
- 115
- Issue
- 3
- Pages
- 538-546
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2135960088
- Cited by
- 288
- References
- 68
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.